Bipolar DisorderDepressive DisordersSchizophreniaDMT

A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)

This article (2017) presents a case study of a physician who attempted to self-medicate with DMT in order to treat their bipolar depression (BD). However, the paper goes beyond the case study to discuss DMT in general terms, as well.

Authors

  • Brown, T.
  • Shao, W.
  • Ayub, S.

Published

Journal of Psychoactive Drugs
individual Study

Abstract

N,N-dimethyltryptamine (DMT) is a psychoactive substance that has been gaining popularity in therapeutic and recreational use. This is a case of a physician who chronically took DMT augmented with phenelzine in an attempt to self-medicate refractory bipolar depression. His presentation of altered mental status, mania, and psychosis is examined in regards to his DMT use. This case discusses DMT, the possible uses of DMT, and the theorized mechanism of DMT in psychosis and treatment of depression, particularly involving its agonist activity at 5-HT1A, 5-HT2A, and 5-HT2C. It is also important to recognize the dangers of self-medication, particularly amongst physicians.

Available with Blossom Pro

Research Summary of 'A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)'

Introduction

DMT (N,N-dimethyltryptamine) is a naturally occurring psychoactive compound found in plants such as Psychotria viridis and is a primary active ingredient in the South American brew ayahuasca. Recent years have seen renewed interest in DMT's potential antidepressant effects and a rise in recreational and therapeutic use, including travel to spiritual retreats. Population survey data cited in the extracted text indicate a relatively high proportion of new users (24%) and a lifetime prevalence of 8.9% for DMT, but the neuropsychiatric effects of chronic use and its utility in treating depression remain speculative and incompletely characterised. Brown and colleagues present a single-patient case report describing a retired 40-year-old psychiatrist with bipolar I disorder who chronically self-administered vaporised DMT, later combined with the monoamine oxidase inhibitor phenelzine, in an attempt to treat refractory depression. The report aims to document his acute presentation of altered mental status, mania, and psychosis, to explore possible mechanisms linking DMT to these neuropsychiatric manifestations, and to highlight the hazards of self-medication, particularly among physicians.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (10)

Papers cited by this study that are also in Blossom

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)

420 cited
Ayahuasca: pharmacology, neuroscience and therapeutic potential

Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Brain Research Bulletin (2016)

Ayahuasca dimethyltryptamine, and psychosis: a systematic review of human studies

Dos Santos, R. G., Hallak, J. E., Bouso, J. C. · Therapeutic Advances in Psychopharmacology (2017)

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · brazilian Journal of Psychiatry (2016)

130 cited
Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions

Liester, M. B., Prickett, J. I. · Journal of Psychoactive Drugs (2012)

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Riba, J., Mcilhenny, E. H., Valle, M. et al. · Drug Testing and Analysis (2012)

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression a SPECT study

Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)

380 cited
Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report

Szmulewicz, A. G., Valerio, M. P., Smith, J. M. · International Journal of Bipolar Disorders (2015)

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans

Valle, M., Maqueda, A. E., Rabella, M. et al. · European Neuropsychopharmacology (2016)

145 cited
Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

Winstock, A. R., Kaar, S., Borschmann, R. · Journal of Psychopharmacology (2013)

89 cited

Cited By (5)

Papers in Blossom that reference this study

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Dursun, S. M., Kelly, J. R., Gillan, C. M. et al. · Frontiers in Psychiatry (2021)

Psychedelic perceptions: mental health service user attitudes to psilocybin therapy

Corrigan, K., Haran, M., Mccandliss, C. et al. · Irish Journal of Medical Science (2021)

Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Systematic Review of Published Case Studies

Gard, D. E., Pleet, M. M., Bradley, E. R. et al. · Journal of Affective Disorders (2021)

The History of Psychedelics in Psychiatry

Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.